NEWS DESK

CSTL Stock News, News Score & What It Could Mean

Castle Biosciences, Inc. - Common stock (CSTL) is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
OPEN ON TRADINGVIEW ↗TRADE THIS STOCK
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
50/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Low
Headline depth
Last Price
DATA UNAVAILABLE
Trend Context
Mixed / range
Latest briefing

What's happening with CSTL

Investing.com UK6 Jul 2026

Derek Maetzold, pres. & CEO, sells $238,916 of Castle Biosciences stock - Investing.com UK

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNTUFUcFVnXzJkUHNUZE5jTklvWFRUelB0WUw5cm5maHBXNnRYemh5YXRtOWpFS0t6eTJranRvYU1keUZFZFlTVm5lX3ZNdXg5TVdhS0F2V2g5ckNRRUlrV01GdWNldzE3eExUbVBmY2lNTTJoVWdSV09hU1FFOHhyaUEyTWJnQWc5UkRoajFwYnRDbnpEWVJZX2ZUcE9yLWVfVXA5allQNUZSWG1vVVdGQU5fZHMtdk1KeER0MXJLWE1Ja2Na?oc=5" target="_blank">Derek Maetzold, pres. & CEO, sells $238,916 of Castle Biosciences stock</a>&nbsp;&nbsp;<font color="#6f6f6f">Investing.com UK</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Stock Titan19 Jun 2026

Castle Biosciences awards RSUs to 172 employees in hiring push - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNYnpyQmJfS3o4UDRZcDVzdTBXeDV4MTBMMHpkSmsyVkd0VkFOdjBZRjREaDNFTC1zWFFybUxmcDFjMGVuZnN6c3pxcTVlMFdCV1g2VkFiRktMeFZyUGxQQWJFdVRsalFuSXNOMzB5SmFPMm4zTlVnSTFYU2hhbU4wWGVGN09LQ3lHTkV1M205clhuaWdfb0dXQ3RHVmxYU1lwMUdiZF9DZGczVGk4MGc4SmR4cTdwS0JaWDk2cQ?oc=5" target="_blank">Castle Biosciences awards RSUs to 172 employees in hiring push</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Stock Titan18 Jun 2026

Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNYzQ5d0JYRHRWbk9ENjFnRkNpLXl3X2FFcVFYOVp2SjZvT1VNS1VyR1ViU00yZXhjbEhVR2xCODRkdnpTdkJkNll6eFcyNDV4NWtxeGQwcnN0SjQ0aTlDRmlMTG5FU1lNUk50NURjMXNNcm5TcVo3bndIalJYc2o2MDFxNmlOWDdCMFJfRHd6aVVZZjhsZ0JidENTc3VfV09VdHZzMzU0NV90dlVFUjkyRmdpdXcxaWM?oc=5" target="_blank">Castle Biosciences (CSTL) COO sells 8,587 shares, retains over 127K</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Stock Titan
17 Jun 2026
Castle Biosciences (CSTL) CEO Maetzold exercises options, trusts sell 4,172 shares - Stock Titan
Read ↗
Investing.com
23 Apr 2026
Castle Biosciences CEO Maetzold sells $104,708 in shares - Investing.com
Read ↗
Investing.com
19 Mar 2026
Maetzold, Castle Biosciences CEO, sells $500k in CSTL stock - Investing.com
Read ↗
StockInvest.us
12 Dec 2020
Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us
Read ↗
Earnings news

CSTL earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
Stock Titan6 Jul 2026

Castle Biosciences (CSTL) CEO sells 9,836 shares via 10b5-1 plan - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOR21ZRS1WaXFacWc1UE1qNFRWSlN4emtKVGFtWXVQQVh5TWV6Z0Z2cHdhYTNKeGhBOTNlV3Z4RlZOTTlaRzQ0akF4UTVBdC1obkE2MXlxdmpqNk1xRUFNbk9JU1hMYUVCQU5scVdCSDZyWVJ4X2xEeUZzRUZZRHg5R1lmSksxNUNXMnhJaXdUQ1JXVnFGU1drQmNjOGUtS1NPS01FcVFmWDBJaFg0bmNSSGJNWTRKZlE?oc=5" target="_blank">Castle Biosciences (CSTL) CEO sells 9,836 shares via 10b5-1 plan</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

2
Stock Titan6 Jul 2026

Castle Biosciences (CSTL) COO sells 8,586 shares under 10b5-1 plan - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQN1JGT1VsdjFLcjJlQlkybWtrbUhfdVptamh6Q3JISFdoV1pXVmpmODd6M21JaXNGd1VHMEdOSks1alExUHl2SDlSZUdkaHRQaXBQTk5RUS1pdmVEejllTU5PZ28tbGNpN1J1N0xzSjNRQWtMS3VWazBCOVB0UWNXOWdrLUEycWdFMlRHYVpsV2w1NTkwNTAtR1ZJSE44VllkZ2lRSTlvcDBpVkFOdm5WVzg0eTNMcTQ?oc=5" target="_blank">Castle Biosciences (CSTL) COO sells 8,586 shares under 10b5-1 plan</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your CSTL research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.
Stock AnalysisOPEN ON TRADINGVIEW ↗TRADE THIS STOCK